A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis-Reference-Cited by-同舟云学术

A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis

Published:2004 Issue:1 Volume:101 Page:156-163
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Patel Shreyaskumar R.,Papadopolous Nicholas,Raymond A. Kevin,Donato Michele,Seong Chu-Myong,Yasko Alan W.,Lewis Valerae O.,Lin Patrick P.,Champlin Richard,Benjamin Robert S.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference20 articles.

1. Cancer Statistics, 2004

2. Prognostic Variables in Osteosarcoma: A Multi-Institutional Study

3. Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

4. Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent and Ongoing Research into Metastatic Osteosarcoma Treatments;International Journal of Molecular Sciences;2022-03-30

2. Assessment of the Nutraceutical Effects of Oleuropein and the Cytotoxic Effects of Adriamycin, When Administered Alone and in Combination, in MG-63 Human Osteosarcoma Cells;Nutrients;2021-01-25

3. Zoledronic Acid: Pleiotropic Anti-Tumor Mechanism and Therapeutic Outlook for Osteosarcoma;Current Drug Targets;2018-03-19

4. Soft Tissue Sarcomas;Holland‐Frei Cancer Medicine;2017-02-26

5. Family Refusal of Chemotherapy for Pediatric Cancer Patients;Journal of Pediatric Hematology/Oncology;2015-07